Incyte Corp (NASDAQ:INCY)

During the Trading Day
110.15 +2.01 / +1.86%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
110.15 -0.003 / -0.00%
 
Volume: 72.6K

Today’s Trading

Previous close108.14
Today’s open107.90
Day’s range107.06 - 111.08
Volume1,245,560
Average volume (3 months)1,179,936
Market cap$19.4B
Dividend yield--
Data as of 4:14pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+11.83%
Earnings growth (next 5 years)+219.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

----
BMRNBiomarin Pharmaceuti...-1.82-1.43%
HSPHospira Inc-0.02-0.02%
MNKMallinckrodt Plc-0.74-0.57%
Data as of 4:02pm ET, 05/29/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers